Endoglin (CD105) and vascular endothelial growth factor (VEGF) as prognostic markers in prostatic adenocarcinoma

被引：0
|
作者：
El-Gohary, YM [1 ]
Saad, RS [1 ]
Tung, M [1 ]
Olson, PR [1 ]
Cohen, JK [1 ]
Miller, R [1 ]
Liu, YL [1 ]
Silverman, JF [1 ]
机构：
[1] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
来源：
MODERN PATHOLOGY | 2005年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
637
引用
收藏
页码：138A / 139A
页数：2
相关论文
共 50 条
  • [41] Angiogenic markers endoglin and vascular endothelial growth factor in gastroenteropancreatic neuroendocrine tumors
    Kuiper, Patricia
    Hawinkels, Lukas J. A. C.
    de Jonge-Muller, Eveline S. M.
    Biemond, Izak
    Lamers, Cornelis B. H. W.
    Verspaget, Hein W.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (02) : 219 - 225
  • [42] Expression of vascular endothelial growth factor (VEGF) and assessment of microvascular density with CD34 as prognostic markers for endometrial carcinoma
    Guset, G.
    Costi, Simona
    Lazar, Elena
    Dema, Alis
    Cornianu, Marioara
    Vernic, Corina
    Paiusan, L.
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2010, 51 (04): : 677 - 682
  • [43] PROGNOSTIC ROLE OF CD44 EXPRESSION AND NEOVASCULARIZATION DETERMINED BY ENDOGLIN (CD105) IN GLIOBLASTOMA PATIENTS
    Mihic, Josip
    Rotim, Kresimir
    Vucic, Majda
    Dragicevic, Ida Hude
    Boric, Marta
    Lugovic-Mihic, Liborija
    ACTA CLINICA CROATICA, 2019, 58 (03) : 455 - 462
  • [44] Trasforming Growth Factor-β Binding Receptor Endoglin (Cd105) Expression in Esophageal Cancer and in Adjacent Nontumorous Esophagus as Prognostic Predictor of Recurrence
    Solerio, D.
    Camandona, M.
    Bertoldo, U.
    Bronda, M.
    Martino, P.
    Bellone, G.
    Gasparri, G.
    PROCEEDINGS OF THE 11TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY FOR DISEASES OF THE ESOPHAGUS, 2008, : 259 - 263
  • [45] Transforming growth factor-β binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence
    Bellone, Graziella
    Solerio, Dino
    Chiusa, Luigi
    Brondino, Gabriele
    Carbone, Anna
    Prati, Adriana
    Scirelli, Tiziana
    Camandona, Michele
    Palestro, Giorgio
    Poli, Marcello Dei
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (11) : 3232 - 3242
  • [46] CD105 AND PLACENTAL GROWTH FACTOR - PROGNOSTIC FACTORS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Sujka-Kordowska, P.
    Malinska, A.
    Ostalska-Nowicka, D.
    Zabel, M.
    Nowicki, M.
    ANNALS OF HEMATOLOGY, 2013, 92 : S27 - S27
  • [47] Transforming Growth Factor-β Binding Receptor Endoglin (CD105) Expression in Esophageal Cancer and in Adjacent Nontumorous Esophagus as Prognostic Predictor of Recurrence
    Graziella Bellone
    Dino Solerio
    Luigi Chiusa
    Gabriele Brondino
    Anna Carbone
    Adriana Prati
    Tiziana Scirelli
    Michele Camandona
    Giorgio Palestro
    Marcello Dei Poli
    Annals of Surgical Oncology, 2007, 14 : 3232 - 3242
  • [48] Endoglin (CD105) expression on microvessel endothelial cells in juvenile nasopharyngeal angiofibroma: Tissue microarray analysis and association with prognostic significance
    Wang, Jing-Jing
    Sun, Xi-Cai
    Hu, Li
    Liu, Zhuo-Fu
    Yu, Hua-Peng
    Li, Han
    Wang, Shu-Yi
    Wang, De-Hui
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (12): : 1719 - 1725
  • [49] MicroRNA and vascular endothelial growth factor (VEGF) as new useful markers in the diagnosis of benign prostatic hyperplasia in dogs
    Wieszczeczy, Michal
    Krakowski, Leszek
    Opielak, Grzegorz
    Krakowska, Izabela
    Furmaga, Jacek
    Brodzki, Piotr
    Bochniarz, Mariola
    Dabrowski, Roman
    Piech, Tomasz
    Zdzisinska, Barbara
    Adaszek, Lukasz
    THERIOGENOLOGY, 2021, 171 : 113 - 118
  • [50] Endothelial cells of oral pyogenic granulomas express eNOS and CD105/endoglin: an immunohistochemical study
    Vassilopoulos, Spyridon I.
    Tosios, Konstantinos I.
    Panis, Vassilios G.
    Vrotsos, John A.
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2011, 40 (04) : 345 - 351
12345